The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity

Toxicology Letters

Volumn 116, Issue 3, 2000, Pages 171-181

  Wong, Simon G W ^a   Card, Jeffrey W ^a   Racz, William J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Bromobenzene; Furosemide; Glutathione; Hepatotoxicity; Mitochondria; Oxidative phosphorylation

Indexed keywords

ALANINE AMINOTRANSFERASE; BROMOBENZENE; FUROSEMIDE; GLUTATHIONE; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COVALENT BOND; LIVER TOXICITY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY CHAIN; RESPIRATORY FUNCTION;

ADENOSINE DIPHOSPHATE; ANIMAL; BROMOBENZENES; FUROSEMIDE; GLUTATHIONE; LIVER; MALE; MICE; MITOCHONDRIA; OXYGEN CONSUMPTION; SUCCINIC ACID; SUPPORT, NON-U.S. GOV'T;

EID: 0034674888     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(00)00218-6     Document Type: Article

References (34)

1. Casini A.F., Pompella A., Comporti M. Liver glutathione depletion induced by bromobenzene, iodobenzene, and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis. Am. J. Pathol. 118:1985;225-237.
2. Casini A.F., Maellaro E., Pompella A., Ferrali M., Comporti M. Lipid peroxidation, protein thiols and calcium homeostasis in bromobenzene-induced liver damage. Biochem. Pharmacol. 36:1987;3689-3695.
3. Chance B., Williams G. A simple and rapid assay of oxidative phosphorylation. Nature. 175:1955;1120-1121.
4. Cohen S.D., Pumford N.R., Khairallah E.A., Boekelheide K., Pohl L.R., Amouzadeh H.R., Hinson J.A. Selective protein covalent binding and target organ toxicity. (review). Toxicol. Appl. Pharmacol. 143:1997;1-12.
5. Donnelly P.J., Walker R.M., Racz W.J. Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Arch. Toxicol. 68:1994;110-118.
6. Duthie S.J., Melvin W.T., Burke M.D. Bromobenzene detoxification in the human liver-derived HepG2 cell line. Xenobiotica. 24:1994;265-279.
7. Estabrook R.W. Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Estabrook R.W., Pullman M.E. Methods in Enzymology. 10:1967;41-47 Academic Press, New York.
8. Grewal K.K., Rafeiro E., Racz W.J. Bromobenzene and furosemide hepatotoxicity: alterations in glutathione, protein thiols, and calcium. Can. J. Physiol. Pharmacol. 74:1996;257-264.
9. Jewell S.A., Bellomo G., Thor H., Orrenius S., Smith M. Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science. 217:1982;1257-1259.
10. Johnson D., Lardy H. Isolation of liver and kidney mitochondria. Estabrook R.W., Pullman M.E. Methods in Enzymology. 10:1967;Academic Press, New York.
11. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 11:1974;151-169.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
13. Maellaro E., Del Bello B., Casini A.F., Comporti M., Ceccarelli D., Muscatello U., Masini A. Early mitochondrial dysfunction in bromobenzene treated mice: a possible factor of liver injury. Biochem. Pharmacol. 40:1990;1491-1497.
14. Manuel M.A., Weiner M.W. Effects of ethacrynic acid and furosemide on isolated rat kidney mitochondria: inhibition of electron transport in the region of phosphorylation site II. J. Pharmacol. Exp. Ther. 198:1976;209-221.
15. Masini A., Ceccarelli D., Gallesi D., Giovannini F., Trenti T. Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats. The critical role for mitochondrial reduced glutathione. Biochem. Pharmacol. 47:1994;217-224.
16. Massey T.E., Walker R.M., McElligott T.F., Racz W.J. Furosemide toxicity in isolated mouse hepatocyte suspensions. Toxicology. 43:1987;149-160.
17. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta. 1271:1995;35-42.
18. Mennes W.C., van Holsteijn C.W., Noordhoek J., Blaauboer B.J. Comparative cytotoxicty of bromobenzene in primary cultures of rat and hamster hepatocytes and its relation to biotransformation. Toxicol. Vitro. 5:1991;63-70.
19. Meredith M.J., Reed D.J. Status of the mitochondrial pool of glutathione in the isolated hepatocyte. J. Biol. Chem. 257:1982;3747-3753.
20. Mitchell J.R., Potter W.Z., Hinson J.A., Jollow D.J. Furosemide-induced hepatic and renal tubular necrosis I. Effects of treatments which alter drug metabolizing enzymes. Fed. Proc. 332:1973;305.
21. Mitchell J.R., Potter W.Z., Hinson J.A., Jollow D.J. Hepatic necrosis caused by furosemide. Nature. 251:1974;508-511.
22. Mitchell J.R., Smith C.V., Lauterburg B.H., Hughes H., Corcoran G.B., Horning E.C. Reactive metabolites and the pathophysiology of acute lethal cell injury. Mitchell J.R., Horning M.G. Drug Metabolism and Drug Toxicity. 1984;301-319 Raven Press, New York.
23. Orita Y., Fukuhara Y., Yanase M., Ando A., Okada N., Abe H. Effect of furosemide on mitochondrial electron transport system and oxidative phosphorylation. Arzneimittelforschung. 33:1983;1446-1450.
24. Pumford N.R., Halmes N.C. Protein targets of xenobiotic reactive intermediates. Ann. Rev. Pharmacol. Toxicol. 37:1997;91-117.
25. Reeve J., Kuhlenkamp J., Kaplowitz N. Estimation of glutathione in rat liver by reversed-phase high performance liquid chromatography: separation of cystein and γ-glutamylcystein. J. Chromatogr. 194:1980;424-428.
26. Shan X., Jones D.P., Hashmi M., Anders M.W. Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem. Res. Toxicol. 6:1993;75-81.
27. Slaughter D.E., Hanzlik R.P. Identification of epoxide- and quinone-derived bromobenzene adducts to protein sulfur nucleophiles. Chem. Res. Toxicol. 4:1991;349-359.
28. Smith C.V., Jones D.P., Guenthner T.M., Lash L.H., Lauterburg B.H. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol. Appl. Pharmacol. 140:1996;1-12.
29. Sordhal L.A., Johnson C., Bailock Z.R., Shwartz A. The mitochondrion. Methods in Pharmacology. 1:1971;247-286 Appleton-Century-Crofts, New York.
30. Takeyama N., Matsuo N., Tanaka T. Oxidative damage to mitochondria is mediated by the Ca(2+) dependent inner-membrane permeability transition. Biochem. J. 294:1993;719-725.
31. Thor H., Moldeus P., Kristoferson A., Hogberg J., Reed D.J., Orrenius S. Metabolic activation and hepatotoxicity. Metabolism of bromobenzene in isolated hypatocytes. Arch. Biochem. Biophys. 188:1978;114-121.
32. Tummino P., Gafni A. A comparative study of succinate-supported respiration and ATP/ADP translocation in liver mitochondria from adult and old rats. Mech. Ageing Dev. 59:1991;177-188.
33. Tzagoloff A. Mitochondria. 1984;131-135 Plenum Press, New York.
34. Walker R.M., McElligott T.F. Furosemide induced hepatotoxicity. J. Pathol. 135:1981;301-314.